Synthesis of ponatinib analogues as novel inhibitors of leukemia stem cells.

To synthesize new analogues of ponatinib and evaluate anti-leukemia cells and cytotoxicity. The inhibitory activity of compounds and against K562 and HL60 cells was comparable to that of ponatinib (IC = 0.74, 0.